Next-Generation Sequencing Informatics Market Report 2026

Next-Generation Sequencing Informatics Market Overview

• Next-Generation Sequencing Informatics market size has reached to $10.23 billion in 2025 • Expected to grow to $22.14 billion in 2030 at a compound annual growth rate (CAGR) of 16.6% • Growth Driver: Increasing Adoption Of Personalized Medicine Fueling The Growth Of The Market Due To Advancements In Genomics And Tailored Treatment Strategies • Market Trend: Advanced Cloud-Based Platforms Streamline Genomic Workflows • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Next-Generation Sequencing Informatics Market?

Next-generation sequencing (NGS) informatics refers to the use of computational tools and algorithms to process, analyze, and interpret massive volumes of DNA or RNA sequencing data generated by next-generation sequencing (NGS) technologies. Its primary purpose is to identify genetic variations, mutations, and expression patterns efficiently, enabling applications in genomics research, personalized medicine, diagnostics, and drug development. The main offerings of next-generation sequencing (NGS) informatics are software, platforms, and services. Software refers to computer programs and bioinformatics tools designed to process, analyze, interpret, and visualize large-scale genomic data generated by next-generation sequencing (NGS) platforms. The products and services encompass storage and computing tools, commercial data analysis, data interpretation and reporting tools, informatics services, and laboratory information management systems (LIMS) and are deployed through cloud, on-premise, and hybrid modes. These informatics find applications in research and development, clinical diagnostics, drug discovery, and agrigenomics, serving end users such as academic and research institutes, pharmaceutical and biotechnology companies, hospitals and clinical laboratories, and agricultural biotechnology companies.

What Is The Next-Generation Sequencing Informatics Market Growth Forecast?

The next-generation sequencing informatics market size is expected to see rapid growth in the next few years. It will grow to $22.14 billion in 2030 at a compound annual growth rate (CAGR) of 16.6%. The growth in the forecast period can be attributed to technological advancements in ngs informatics software, adoption of cloud-based genomic platforms, increasing collaborations between biotech and pharma companies, growing prevalence of genetic disorders, integration of ai and machine learning in genomics analysis. Major trends in the forecast period include AI-driven genomic data analysis, cloud-based sequencing platforms, personalized medicine applications, automation in NGS workflows, integration of IoT in genomic research.

Global Next-Generation Sequencing Informatics Market Segmentation

1) By Offering: Software, Platforms, Services 2) By Product And Services: Storage And Computing Tools, Commercial Data Analysis, Data Interpretation And Reporting Tools, Informatics Services 3) By Deployment Mode: Cloud, On-Premise, Hybrid 4) By Application: Research And Development, Clinical Diagnostics, Drug Discovery, Agrigenomics 5) By End User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Hospitals And Clinical Laboratories, Agricultural Biotechnology Companies Subsegments: 1) By Software: Data Analysis Software, Data Management And Storage Tools, Workflow Management Software, Sequence Alignment Tools, Variant Analysis Software, Clinical Interpretation Software 2) By Platforms: On-Premises Platforms, Cloud-Based Platforms, Hybrid Platforms 3) By Services: Data Analysis Services, Consulting And Implementation Services, Data Management And Storage Services, Technical Support And Maintenance Services, Training And Education Services

What Is The Driver Of The Next-Generation Sequencing Informatics Market?

The increasing adoption of personalized medicine is expected to propel the growth of the next-generation sequencing informatics market going forward. Personalized medicine refers to a medical approach that tailors treatment and prevention strategies to an individual’s unique genetic makeup, lifestyle, and environment. The increasing adoption of personalized medicine is primarily due to advancements in genomics, which enable precise identification of genetic variations and tailored treatments for individuals. Next-generation sequencing informatics enhances personalized medicine by providing comprehensive genomic data analysis, making it ideal for tailored treatment strategies and precision healthcare. It reduces diagnostic uncertainty by identifying genetic variations and predicting disease risk, improving clinical decision-making and patient outcomes. For instance, in February 2024, according to the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, the U.S. Food and Drug Administration (FDA) approved 26 new personalized medicines in 2023, a significant increase from the 12 approved in 2022. Therefore, the increasing adoption of personalized medicine is driving the growth of the next-generation sequencing informatics industry.

Key Players In The Global Next-Generation Sequencing Informatics Market

Major companies operating in the next-generation sequencing informatics market are DNAnexus Inc., SOPHiA GENETICS SA, DNASTAR Inc., Geneious Biomatters Ltd., CosmosID Inc., QIAGEN N.V., Seven Bridges Genomics Inc., PierianDx Inc., Fabric Genomics Inc., Golden Helix Inc., Partek Incorporated, Real Time Genomics Inc., Sentieon Inc., Roche NimbleGen Inc., Agilent Alissa Interpret, WuXi NextCODE Genomics, DNAVision SA, Genoox Ltd., Congenica Ltd., PierianDx Holdings, Bionano Genomics Inc.

Global Next-Generation Sequencing Informatics Market Trends and Insights

Major companies operating in the next-generation sequencing informatics (NGS) market are focusing on developing advanced solutions, such as cloud-based platforms, to improve scalability, enhance data security, and streamline genomic workflows. Cloud-based platforms refer to digital infrastructures that enable researchers and clinicians to store, process, and analyze large volumes of sequencing data either on remote servers or within local institutional environments. For instance, in March 2023, Illumina Inc., a US-based biotechnology company, launched Connected Insights, a new cloud-based software designed for tertiary analysis of clinical next-generation sequencing (NGS) data. It streamlines genomic data interpretation and reporting, integrates over 45 third-party knowledge sources, and reduces turnaround times for clinical reports. It automates variant interpretation and report generation, reducing manual effort and standardizing workflows across diverse assay types, such as comprehensive genomic profiling (CGP) panels, whole-exome sequencing (WES), and transcriptomic data.

What Are Latest Mergers And Acquisitions In The Next-Generation Sequencing Informatics Market?

In May 2025, GeneDx Inc., a US-based biotechnology company, acquired Fabric Genomics Inc. for an undisclosed amount. With this acquisition, GeneDx aims to enhance its capabilities in AI-driven genomic interpretation, expand access to advanced NGS informatics solutions, and strengthen its offerings in rare disease diagnostics, hereditary risk assessment, and precision medicine. Fabric Genomics Inc. is a US-based biotechnology company specializing in next-generation sequencing (NGS) informatics.

Regional Outlook

North America was the largest region in the next-generation sequencing informatics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Next-Generation Sequencing Informatics Market?

The next-generation sequencing informatics market includes revenues earned by entities through data analysis and interpretation, bioinformatics pipeline development, genomic data storage and management, variant annotation and prioritization, and reporting and visualization. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.